Phyllodes tumour: Difference between revisions
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 133: | Line 133: | ||
Epithelial component: | Epithelial component: | ||
*CK7 +ve. | *CK7 +ve. | ||
Stromal cells:<ref>{{cite journal |authors=Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO |title=An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast |journal=Hum Pathol |volume=34 |issue=10 |pages=1009–15 |date=October 2003 |pmid=14608534 |doi=10.1053/s0046-8177(03)00414-3 |url=}}</ref> | *ER. | ||
*PR. | |||
Stromal cells:<ref name=pmid14608534>{{cite journal |authors=Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO |title=An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast |journal=Hum Pathol |volume=34 |issue=10 |pages=1009–15 |date=October 2003 |pmid=14608534 |doi=10.1053/s0046-8177(03)00414-3 |url=}}</ref> | |||
*CD34 +ve. | *CD34 +ve. | ||
*BCL2 +ve. | *BCL2 +ve. | ||
*CK -ve. | *CK -ve. | ||
*GATA-3 -ve.<ref name=pmid23375642>{{cite journal |authors=Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani P |title=GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas |journal=Hum Pathol |volume=44 |issue=7 |pages=1341–9 |date=July 2013 |pmid=23375642 |pmc=3991123 |doi=10.1016/j.humpath.2012.11.003 |url=}}</ref> | |||
==Sign out== | ==Sign out== | ||